(19)
(11)
EP 0 628 079 A1
(12)
(43)
Date of publication:
14.12.1994
Bulletin 1994/50
(21)
Application number:
93904270.0
(22)
Date of filing:
26.02.1993
(51)
International Patent Classification (IPC):
G01N
33/
53
( . )
A61K
39/
395
( . )
C07K
7/
06
( . )
C07K
16/
00
( . )
C12N
15/
51
( . )
C12P
21/
08
( . )
C12Q
1/
70
( . )
A61K
39/
00
( . )
A61K
39/
29
( . )
A61P
31/
12
( . )
C07K
14/
18
( . )
C12N
15/
09
( . )
C12P
21/
02
( . )
C12Q
1/
68
( . )
G01N
33/
576
( . )
(86)
International application number:
PCT/GB1993/000410
(87)
International publication number:
WO 1993/017111
(
02.09.1993
Gazette 1993/21)
(84)
Designated Contracting States:
AT BE CH DE ES FR GB IE IT LI NL SE
(30)
Priority:
28.02.1992
GB 19920004274
(71)
Applicant:
THE WELLCOME FOUNDATION LIMITED
London NW1 2BP (GB)
(72)
Inventor:
PIKE, Ian
Bromley, Kent. BR2 9RX (GB)
(74)
Representative:
Marchant, James Ian, et al
Elkington and Fife Prospect House 8 Pembroke Road
Sevenoaks, Kent TN13 1XR
Sevenoaks, Kent TN13 1XR (GB)
(54)
HEPATITIS C VIRUS PEPTIDES